Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Fluorine-18-MK 6240 (Primary) ; Levetiracetam (Primary)
- Indications Mild cognitive impairment; Neurodegenerative disorders; Stroke; Traumatic brain injuries
- Focus Diagnostic use
- 07 May 2018 New trial record